|
|
Boston University
|
7
|
|
|
Zero Stage Capital
|
6
|
|
|
BioSurface Technology
|
4
|
|
|
Peptimmune
|
4
|
|
|
Massachusetts General Hospital
|
4
|
|
|
Hydrocision Inc
|
3
|
|
|
Seaflower Associates Inc
|
3
|
|
|
Nephros
|
2
|
|
|
Vidus Ocular Inc
|
2
|
|
|
Biotrove Inc
|
2
|
|
|
Harvard Medical School
|
2
|
|
|
Echelon Ventures
|
2
|
|
|
U S Genomics
|
2
|
|
|
Spherics Inc
|
2
|
|
|
RenaMed Biologics Inc
|
2
|
|
|
Pathogenetix Inc
|
1
|
|
|
US Genomics
|
1
|
|
|
RenaMed Biologics
|
1
|
|
|
Biolink Corp
|
1
|
|
|
Slater Center for Biomedical Technology
|
1
|